Haverford Trust Company’s Novartis NVS Stock Holding History

Haverford Trust Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.34M	Hold	28,382	–	–	0.04%	125
2025 Q4	$3.91M	Sell	28,382 -492	-2%	-$64.4K	0.03%	133
2025 Q3	$3.7M	Sell	28,874 -8,364	-22%	-$1.02M	0.03%	137
2025 Q2	$4.51M	Sell	37,238 -27	-0.1%	-$3.04K	0.04%	129
2025 Q1	$4.15M	Sell	37,265 -674	-2%	-$71.8K	0.04%	130
2024 Q4	$3.69M	Buy	37,939 +516	+1%	+$55K	0.04%	136
2024 Q3	$4.3M	Buy	37,423 +746	+2%	+$84.6K	0.04%	128
2024 Q2	$3.9M	Sell	36,677 -1,166	-3%	-$117K	0.04%	131
2024 Q1	$3.66M	Buy	37,843 +3,027	+9%	+$310K	0.04%	138
2023 Q4	$3.52M	Buy	34,816 +3,586	+11%	+$346K	0.04%	131
2023 Q3	$3.18M	Sell	31,230 -89	-0.3%	-$9.03K	0.04%	130
2023 Q2	$3.16M	Sell	31,319 -2,397	-7%	-$240K	0.04%	127
2023 Q1	$3.1M	Buy	33,716 +1,631	+5%	+$142K	0.04%	126
2022 Q4	$2.91M	Sell	32,085 -414	-1%	-$34.9K	0.04%	128
2022 Q3	$2.47M	Hold	32,499	–	–	0.03%	134
2022 Q2	$2.75M	Sell	32,499 -66	-0.2%	-$5.79K	0.04%	129
2022 Q1	$2.86M	Sell	32,565 -10,045	-24%	-$870K	0.03%	133
2021 Q4	$3.73M	Hold	42,610	–	–	0.04%	122
2021 Q3	$3.48M	Sell	42,610 -7,470	-15%	-$672K	0.04%	127
2021 Q2	$4.57M	Buy	50,080 +2,300	+5%	+$205K	0.05%	115
2021 Q1	$4.08M	Buy	47,780 +9,037	+23%	+$811K	0.05%	107
2020 Q4	$3.66M	Buy	38,743 +4,200	+12%	+$367K	0.05%	100
2020 Q3	$3M	Sell	34,543 -653	-2%	-$56.6K	0.05%	105
2020 Q2	$3.07M	Buy	35,196 +20	+0.1%	+$1.73K	0.05%	99
2020 Q1	$2.9M	Buy	35,176 +8,589	+32%	+$766K	0.06%	97
2019 Q4	$2.52M	Hold	26,587	–	–	0.04%	116
2019 Q3	$2.31M	Sell	26,587 -700	-3%	-$62.9K	0.04%	120
2019 Q2	$2.49M	Sell	27,287 -3,194	-10%	-$270K	0.04%	114
2019 Q1	$2.63M	Sell	30,481 -220	-0.7%	-$17.7K	0.05%	108
2018 Q4	$2.36M	Buy	30,701 +693	+2%	+$53.9K	0.05%	107
2018 Q3	$2.32M	Buy	30,008 +11	+0%	+$813	0.04%	120
2018 Q2	$2.03M	Sell	29,997 -6,794	-18%	-$469K	0.04%	121
2018 Q1	$2.67M	Buy	36,791 +1,355	+4%	+$103K	0.05%	103
2017 Q4	$2.67M	Buy	35,436 +338	+1%	+$25.5K	0.05%	103
2017 Q3	$2.7M	Buy	35,098 +75	+0.2%	+$5.66K	0.06%	95
2017 Q2	$2.62M	Sell	35,023 -157	-0.4%	-$11.1K	0.06%	92
2017 Q1	$2.34M	Sell	35,180 -1,271	-3%	-$84.7K	0.05%	95
2016 Q4	$2.38M	Buy	36,451 +2,171	+6%	+$141K	0.06%	93
2016 Q3	$2.42M	Buy	34,280 +2,606	+8%	+$190K	0.06%	87
2016 Q2	$2.34M	Sell	31,674 -2,860	-8%	-$198K	0.06%	89
2016 Q1	$2.24M	Sell	34,534 -95	-0.3%	-$6.46K	0.06%	92
2015 Q4	$2.67M	Sell	34,629 -4,059	-10%	-$322K	0.07%	85
2015 Q3	$3.19M	Buy	38,688 +3,682	+11%	+$328K	0.09%	76
2015 Q2	$3.08M	Sell	35,006 -176	-0.5%	-$16.1K	0.08%	79
2015 Q1	$3.11M	Buy	35,182 +309	+0.9%	+$27.4K	0.09%	83
2014 Q4	$2.9M	Buy	34,873 +279	+0.8%	+$23.1K	0.08%	86
2014 Q3	$2.92M	Sell	34,594 -1,254	-3%	-$101K	0.09%	84
2014 Q2	$2.91M	Sell	35,848 -6,581	-16%	-$518K	0.09%	84
2014 Q1	$3.23M	Sell	42,429 -923,054	-96%	-$67.3M	0.1%	78
2013 Q4	$69.5M	Buy	965,483 +1,246	+0.1%	+$86.6K	1.95%	19
2013 Q3	$66.3M	Sell	964,237 -1,987	-0.2%	-$131K	2.41%	18
2013 Q2	$61.2M	Buy	+966,224	New	+$62.9M	2.02%	19

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Haverford Trust Company's NVS Position: Q1 2026 in Review

Haverford Trust Company held its Novartis (NVS) position steady in Q1 2026 at 28,382 shares worth $4.34M. The position accounts for 0.04% of the portfolio, ranked #125.

Haverford Trust Company first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.5M in Q4 2013. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Haverford Trust Company held 28,382 shares of Novartis worth $4.34M as of Q1 2026.
Haverford Trust Company left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.04% of Haverford Trust Company's portfolio in Q1 2026, its #125 holding.
Haverford Trust Company first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
Haverford Trust Company's Novartis position peaked at $69.5M in Q4 2013.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.